Exelixis, Inc.

NasdaqGS:EXEL 株式レポート

時価総額：US$10.2b

Exelixis マネジメント

マネジメント 基準チェック /44

Exelixisの CEO はMike Morrisseyで、 Jul2010年に任命され、 の在任期間は 14.33年です。 の年間総報酬は$ 16.42Mで、 7.3%給与と92.7%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.56%を直接所有しており、その価値は$ 57.14M 。経営陣と取締役会の平均在任期間はそれぞれ8.5年と7.4年です。

主要情報

Mike Morrissey

最高経営責任者

US$16.4m

報酬総額

CEO給与比率7.3%
CEO在任期間14.3yrs
CEOの所有権0.6%
経営陣の平均在職期間8.5yrs
取締役会の平均在任期間7.4yrs

経営陣の近況

Recent updates

Exelixis: Cabometyx Drives Revenue While Zanzalintinib Emerges As Future Growth Engine

Oct 31

Exelixis, Inc.'s (NASDAQ:EXEL) Shares Leap 25% Yet They're Still Not Telling The Full Story

Oct 31
Exelixis, Inc.'s (NASDAQ:EXEL) Shares Leap 25% Yet They're Still Not Telling The Full Story

Here's Why We Think Exelixis (NASDAQ:EXEL) Is Well Worth Watching

Oct 26
Here's Why We Think Exelixis (NASDAQ:EXEL) Is Well Worth Watching

Getting In Cheap On Exelixis, Inc. (NASDAQ:EXEL) Might Be Difficult

Sep 02
Getting In Cheap On Exelixis, Inc. (NASDAQ:EXEL) Might Be Difficult

Exelixis Comes Up Aces

Aug 08

If EPS Growth Is Important To You, Exelixis (NASDAQ:EXEL) Presents An Opportunity

Jun 14
If EPS Growth Is Important To You, Exelixis (NASDAQ:EXEL) Presents An Opportunity

It's Unlikely That Exelixis, Inc.'s (NASDAQ:EXEL) CEO Will See A Huge Pay Rise This Year

May 24
It's Unlikely That Exelixis, Inc.'s (NASDAQ:EXEL) CEO Will See A Huge Pay Rise This Year

Exelixis' (NASDAQ:EXEL) Strong Earnings Are Of Good Quality

May 07
Exelixis' (NASDAQ:EXEL) Strong Earnings Are Of Good Quality

Exelixis: With Patent Litigation Decision Due Soon, There Are Options

May 02

Exelixis, Inc.'s (NASDAQ:EXEL) Earnings Haven't Escaped The Attention Of Investors

Apr 22
Exelixis, Inc.'s (NASDAQ:EXEL) Earnings Haven't Escaped The Attention Of Investors

Exelixis: Patent Woes And Challenging Market Dynamics Make For A Testy 2024

Mar 28

We Ran A Stock Scan For Earnings Growth And Exelixis (NASDAQ:EXEL) Passed With Ease

Feb 26
We Ran A Stock Scan For Earnings Growth And Exelixis (NASDAQ:EXEL) Passed With Ease

Exelixis: Bullish Despite The High Stakes Game Of Cabometyx Patent Battles

Jan 17

Exelixis, Inc.'s (NASDAQ:EXEL) Revenues Are Not Doing Enough For Some Investors

Dec 27
Exelixis, Inc.'s (NASDAQ:EXEL) Revenues Are Not Doing Enough For Some Investors

An Intrinsic Calculation For Exelixis, Inc. (NASDAQ:EXEL) Suggests It's 49% Undervalued

May 30
An Intrinsic Calculation For Exelixis, Inc. (NASDAQ:EXEL) Suggests It's 49% Undervalued

CEO報酬分析

Exelixis の収益と比較して、Mike Morrissey の報酬はどのように変化したか？
日付総報酬給与会社業績
Sep 30 2024n/an/a

US$467m

Jun 30 2024n/an/a

US$350m

Mar 31 2024n/an/a

US$205m

Dec 31 2023n/an/a

US$208m

Sep 30 2023n/an/a

US$92m

Jun 30 2023n/an/a

US$164m

Mar 31 2023n/an/a

US$154m

Dec 31 2022US$17mUS$1m

US$182m

Sep 30 2022n/an/a

US$308m

Jun 30 2022n/an/a

US$273m

Mar 31 2022n/an/a

US$298m

Dec 31 2021US$8mUS$1m

US$231m

Sep 30 2021n/an/a

US$164m

Jun 30 2021n/an/a

US$94m

Mar 31 2021n/an/a

US$65m

Dec 31 2020n/an/a

US$112m

Sep 30 2020n/an/a

US$152m

Jun 30 2020n/an/a

US$282m

Mar 31 2020n/an/a

US$294m

Dec 31 2019n/an/a

US$321m

Sep 30 2019n/an/a

US$612m

Jun 30 2019n/an/a

US$642m

Mar 31 2019n/an/a

US$650m

Dec 31 2018n/an/a

US$690m

Sep 30 2018n/an/a

US$368m

Jun 30 2018n/an/a

US$323m

Mar 31 2018n/an/a

US$253m

Dec 31 2017n/an/a

US$154m

報酬と市場: Mikeの 総報酬 ($USD 16.42M ) は、 US市場 ($USD 12.66M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Mikeの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Mike Morrissey (63 yo)

14.3yrs

在職期間

US$16,423,307

報酬

Dr. Michael M. Morrissey, Ph.D. also known as Mike, serves as Independent Director at XW Laboratories Inc. Dr. Morrissey serves as Independent Chairman of the Board at Vera Therapeutics, Inc since May 24,...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Stelios Papadopoulos
Co-Founder & Chair of the Board29.9yrsUS$519.97k0.43%
$ 44.2m
Michael Morrissey
CEO, President & Director14.3yrsUS$16.42m0.56%
$ 57.1m
Christopher Senner
Executive VP & CFO9.3yrsUS$4.95m0.16%
$ 16.6m
Dana Aftab
Executive VP of Discovery and Translational Research & Chief Scientific Officer1.9yrsUS$5.65m0.080%
$ 8.1m
Jeffrey Hessekiel
Executive VP & General Counsel10.8yrsUS$4.56m0.11%
$ 11.0m
Amy Peterson
Executive VP1.3yrsUS$7.38m0.10%
$ 10.5m
Susan Hubbard
Executive Vice President of Public Affairs & Investor Relations7.9yrsデータなしデータなし
Tony Redmond
Senior Vice President of Human Resourcesless than a yearデータなしデータなし
Anne Champsaur
Senior Vice President of Drug Safety9.6yrsデータなしデータなし
William Berg
Senior Vice President of Medical Affairs9.2yrsデータなしデータなし
Patrick Haley
Executive Vice President of Commercial7.9yrsUS$4.65m0.039%
$ 4.0m
Stefan Krauss
VP & Head of Business Developmentno dataデータなしデータなし

8.5yrs

平均在職期間

57yo

平均年齢

経験豊富な経営陣: EXELの経営陣は経験豊富で経験豊富です（平均在職期間は8.5年）。

取締役

名称ポジション在職期間報酬所有権
Stelios Papadopoulos
Co-Founder & Chair of the Board29.9yrsUS$519.97k0.43%
$ 44.2m
Michael Morrissey
CEO, President & Director14.3yrsUS$16.42m0.56%
$ 57.1m
Jack Wyszomierski
Independent Director20.8yrsUS$490.97k0.12%
$ 11.8m
George Poste
Independent Director20.3yrsUS$482.22k0.053%
$ 5.3m
Charles Sawyers
Member of the Scientific Advisory Boardno dataデータなしデータなし
Ronald Evans
Member of the Scientific Advisory Boardno dataデータなしデータなし
Sue Eckhardt
Independent Directorless than a yearデータなし0%
$ 0
Mary Beckerle
Independent Directorless than a yearデータなし0%
$ 0
Julie Smith
Independent Director8.2yrsUS$490.92k0.00027%
$ 27.5k
Maria Freire
Independent Director6.6yrsUS$488.72k0.025%
$ 2.6m
Robert Oliver
Independent Director1.5yrsUS$717.44k0.0016%
$ 161.7k
Tomas Heyman
Independent Director1.5yrsUS$716.19k0.0016%
$ 161.7k

7.4yrs

平均在職期間

68yo

平均年齢

経験豊富なボード: EXELの 取締役会 は 経験豊富 であると考えられます ( 7.4年の平均在任期間)。